首页|补肺化瘀通络汤联合沙丁胺醇治疗慢性阻塞性肺疾病患者的临床效果

补肺化瘀通络汤联合沙丁胺醇治疗慢性阻塞性肺疾病患者的临床效果

扫码查看
目的:探讨补肺化瘀通络汤联合沙丁胺醇治疗慢性阻塞性肺疾病(COPD)的临床效果。方法:选取 2022 年8 月—2023 年 8 月黔西南州中医院收治的 260 例COPD患者。随机将其分为对照组和观察组,各 130 例。对照组给予吸入用硫酸沙丁胺醇溶液,观察组在对照组基础上给予补肺化瘀通络汤治疗。比较两组临床疗效,治疗前后肺功能指标、炎症因子、中医症状积分、血气指标、生活质量及安全性。结果:观察组总有效率高于对照组,差异有统计学意义(P<0。05)。治疗后,观察组用力肺活量(FVC)、第 1 秒用力呼气容积(FEV1)、FEV1/FVC%均高于对照组,差异有统计学意义(P<0。05)。治疗后,观察组C反应蛋白(CRP)、白细胞介素-8(IL-8)、肿瘤坏死因子-α(TNF-α)水平均低于对照组,差异有统计学意义(P<0。05)。治疗后,观察组咳嗽咳痰、喘息哮鸣、胸闷气短、痰黏量多评分均低于对照组,差异有统计学意义(P<0。05)。治疗后,观察组动脉血氧分压(PaO2)高于对照组,动脉血二氧化碳分压(PaCO2)低于对照组,差异有统计学意义(P<0。05)。治疗后,观察组疾病影响、活动能力、呼吸症状均低于对照组,差异有统计学意义(P<0。05)。两组不良反应比较,差异无统计学意义(P>0。05)。结论:补肺化瘀通络汤联合沙丁胺醇可提高COPD治疗效果,纠正血气异常,降低炎症因子水平,减轻患者肺损害,安全可靠。
Clinical Effect of Bufei Huayu Tongluo Decoction Combined with Salbutamol in the Treatment of Patients with Chronic Obstructive Pulmonary Disease
Objective:To investigate the clinical effect of Bufei Huayu Tongluo Decoction combined with Salbutamol in the treatment of patients with chronic obstructive pulmonary disease(COPD).Method:A total of 260 COPD patients admitted to Qianxinan Traditional Chinese Medicine Hospital from August 2022 to August 2023 were selected.They were randomly divided into control group and observation group,130 cases in each group.The control group was given Salbutamol Sulfate Solution for Inhalation,and the observation group was given Bufei Huayu Tongluo Decoction on the basis of the control group.The clinical efficacy,pulmonary function index,inflammatory factor,traditional Chinese medicine symptom score,blood gas index,quality of life before and after treatment and safety of the two groups were compared.Result:The total effective rate of the observation group was higher than that of the control group,and the difference was statistically significant(P<0.05).After treatment,forced vital capacity(FVC),forced expiratory volume in the first second(FEV1)and FEV1/FVC%in the observation group were higher than those in the control group,and the differences were statistically significant(P<0.05).After treatment,the levels of C-reactive protein(CRP),interleukin-8(IL-8)and tumor necrosis factor-α(TNF-α)in observation group were lower than those in control group,and the differences were statistically significant(P<0.05).After treatment,the scores of cough and phlegm,wheezing,chest tightness and shortness of breath and excessive phlegm viscosity in observation group were lower than those in control group,and the differences were statistically significant(P<0.05).After treatment,the arterial partial pressure of oxygen(PaO2)in the observation group was higher than that in the control group,and the arterial partial pressure of carbon dioxide(PaCO2)was lower than that in the control group,the differences were statistically significant(P<0.05).After treatment,the disease impact,mobility,respiratory symptoms and total score of the observation group were lower than those of the control group,and the differences were statistically significant(P<0.05).There was no significant difference in adverse reactions between the two groups(P>0.05).Conclusion:Bufei Huayu Tongluo Decoction combined with Salbutamol can improve the therapeutic effect of COPD,correct the abnormal blood gas,reduce the level of inflammatory factors,reduce the lung damage of patients,and is safe and reliable.

Chronic obstructive pulmonary diseaseBufei Huayu Tongluo DecoctionSalbutamolLung functionAdverse effects

魏显国

展开 >

黔西南州中医院 贵州 兴义 562400

慢性阻塞性肺疾病 补肺化瘀通络汤 沙丁胺醇 肺功能 不良反应

2024

中外医学研究
中国医院管理杂志社

中外医学研究

影响因子:1.149
ISSN:1674-6805
年,卷(期):2024.22(26)